首页 > 最新文献

European Journal of Integrative Medicine最新文献

英文 中文
Reflexology specific guidance for using the template for the intervention description and replication (TIDieR): A delphi study 使用干预描述和复制模板(TIDieR)的反射疗法具体指导:德尔菲研究
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-23 DOI: 10.1016/j.eujim.2024.102416
Jacqueline James , Joseph T. Costello , Sally Edwards-Price , Tracey Smith , Amanda McAuley , Barbara E. Scott , Spyridon Dimitrakoulas , Marcia Edwards , Dorothy Kelly , David L. Wayte , Andrea F. Porritt , Amy K. Drahota

Introduction

Reflexology is a holistic, complementary therapy, carried out on the feet, hands, ears, or face. There is no single accepted definition of reflexology, as it encompasses various practices, making it important that research studies articulate exactly what the reflexology intervention entailed.
This study sought to produce reflexology-specific guidance for researchers and practitioners, for use with the Template for the Intervention Description and Replication (TIDieR) checklist, to improve the quality of the documentation of reflexology interventions within the research literature.

Method

This study used the TIDieR checklist as a framework for a three-round Delphi process to gain agreement on what information authors should consider including in their study report to support replication of their intervention. Following the Delphi process two online consolidation meetings were held to agree the wording and examples for the guidance document.

Results

Guidance based on the unique considerations of reflexology interventions was developed for use with the TIDieR checklist.
A diverse group of 43 experts from Europe, North America, Asia, and Australasia, including 40 reflexologists, 9 of whom were also study authors, and 2 methodological specialists contributed to the guidance.
Each Delphi round was completed by 39 to 42 (91 % to 98 %) of the 43 panel members, and 16 (37 %) participated in the consolidation meetings. Consensus was reached on 46 items via the Delphi rounds (36 to be included in the guidance and 10 to be excluded); 38 items failed to reach consensus. The consolidation meetings informed the final wording of the guidance document, covering all the 12 TIDieR domains.

Conclusion

The reflexology-specific guidance strongly advocates for the utilisation of the TIDieR checklist, with elaboration tailored for reflexology as used in various contexts internationally. By serving as a reporting guide for reflexology intervention studies, this tool has the capacity to improve the reporting of reflexology intervention studies, thereby facilitating replicability and promoting greater transparency within the field of reflexology.
导言反射疗法是一种在脚、手、耳朵或面部进行的整体性辅助疗法。本研究旨在为研究人员和从业人员提供针对反射疗法的指导,与干预描述和复制模板(TIDieR)核对表一起使用,以提高研究文献中反射疗法干预的记录质量。方法本研究以 TIDieR 核对表为框架,开展了三轮德尔菲过程,以就作者应考虑在其研究报告中包含哪些信息以支持其干预措施的复制达成一致意见。来自欧洲、北美、亚洲和澳大拉西亚的 43 位专家(包括 40 位反射疗法专家,其中 9 位同时也是研究报告的作者)和 2 位方法论专家组成了一个多元化的小组,为指南的编写做出了贡献。43 位小组成员中有 39 到 42 人(91 % 到 98 %)完成了每轮德尔菲讨论,16 人(37 %)参加了合并会议。德尔菲小组就 46 个项目达成共识(36 个项目纳入指南,10 个项目排除在外);38 个项目未能达成共识。合并会议为指导文件的最终措辞提供了依据,该文件涵盖了 TIDieR 的所有 12 个领域。通过作为反射疗法干预研究的报告指南,该工具能够改进反射疗法干预研究的报告,从而提高反射疗法领域的可复制性和透明度。
{"title":"Reflexology specific guidance for using the template for the intervention description and replication (TIDieR): A delphi study","authors":"Jacqueline James ,&nbsp;Joseph T. Costello ,&nbsp;Sally Edwards-Price ,&nbsp;Tracey Smith ,&nbsp;Amanda McAuley ,&nbsp;Barbara E. Scott ,&nbsp;Spyridon Dimitrakoulas ,&nbsp;Marcia Edwards ,&nbsp;Dorothy Kelly ,&nbsp;David L. Wayte ,&nbsp;Andrea F. Porritt ,&nbsp;Amy K. Drahota","doi":"10.1016/j.eujim.2024.102416","DOIUrl":"10.1016/j.eujim.2024.102416","url":null,"abstract":"<div><h3>Introduction</h3><div>Reflexology is a holistic, complementary therapy, carried out on the feet, hands, ears, or face. There is no single accepted definition of reflexology, as it encompasses various practices, making it important that research studies articulate exactly what the reflexology intervention entailed.</div><div>This study sought to produce reflexology-specific guidance for researchers and practitioners, for use with the Template for the Intervention Description and Replication (TIDieR) checklist, to improve the quality of the documentation of reflexology interventions within the research literature.</div></div><div><h3>Method</h3><div>This study used the TIDieR checklist as a framework for a three-round Delphi process to gain agreement on what information authors should consider including in their study report to support replication of their intervention. Following the Delphi process two online consolidation meetings were held to agree the wording and examples for the guidance document.</div></div><div><h3>Results</h3><div>Guidance based on the unique considerations of reflexology interventions was developed for use with the TIDieR checklist.</div><div>A diverse group of 43 experts from Europe, North America, Asia, and Australasia, including 40 reflexologists, 9 of whom were also study authors, and 2 methodological specialists contributed to the guidance.</div><div>Each Delphi round was completed by 39 to 42 (91 % to 98 %) of the 43 panel members, and 16 (37 %) participated in the consolidation meetings. Consensus was reached on 46 items via the Delphi rounds (36 to be included in the guidance and 10 to be excluded); 38 items failed to reach consensus. The consolidation meetings informed the final wording of the guidance document, covering all the 12 TIDieR domains.</div></div><div><h3>Conclusion</h3><div>The reflexology-specific guidance strongly advocates for the utilisation of the TIDieR checklist, with elaboration tailored for reflexology as used in various contexts internationally. By serving as a reporting guide for reflexology intervention studies, this tool has the capacity to improve the reporting of reflexology intervention studies, thereby facilitating replicability and promoting greater transparency within the field of reflexology.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"72 ","pages":"Article 102416"},"PeriodicalIF":1.9,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142662813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda interventions for non-specific chronic low back pain— protocol for a systematic review and network meta-analysis 阿育吠陀对非特异性慢性腰背痛的干预--系统综述和网络荟萃分析方案
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-19 DOI: 10.1016/j.eujim.2024.102413
Ritu Kumari, Mandip Goyal, Kalpesh Panara

Introduction

Low back pain (570 million prevalent cases worldwide) is the main contributor to the overall burden of musculoskeletal conditions. The most common form of low back pain is non-specific low back pain (NSCLBP) (almost 90 %). There are no treatments that completely cure chronic low back pain. Ayurveda is one of the traditional systems of Indian medicine commonly practiced in Southeast Asian countries. Even though Ayurveda interventions (oral medication or procedure-based treatment or combined therapy) are practiced widely for this condition, there is ambiguity about the hierarchy of treatment. The present review has been planned to compare all the available Ayurveda treatment modalities for NSCLBP in terms of efficacy, and safety, in all the age groups of patients.

Methods

This review will be written in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the PRISMA extension for network meta-analyses. Electronic searches will be carried out in PubMed, Scopus, TRIP, Website of Indexing of Indian Medical Journals, the Cochrane Register for Controlled Trials, The Clinical Trials Registry- India, AYUSH research portal, and Digital Helpline for Ayurveda Research Articles, and other pre-print repositories since its inception till 31st March 2024. Randomized controlled trials, randomized cross-over studies, cluster-randomized studies, and nonrandomized studies of interventions (prospective cohort studies, non-randomized clinical trials) will be included. The risk of bias will be assessed with ROB-2, ROBINS-I, and other revised risk of bias tools for cross-over studies and cluster randomised studies recommended by the Cochrane collaboration. To evaluate the credibility of the findings, the Grading of Recommendations Assessment, Development, and Evaluation method for network meta-analysis will be implemented. A narrative approach to synthesize and report qualitative and quantitative data will be used, and where feasible, we will conduct network meta-analyses using STATA software.

Conclusions

This protocol defines a plan of the study that would facilitate the process of recommending treatment for NSCLBP, by providing a treatment hierarchy of Ayurvedic treatment to the policymakers and stakeholders.
导言腰背痛(全球有 5.7 亿发病病例)是造成肌肉骨骼疾病总体负担的主要因素。最常见的腰背痛是非特异性腰背痛(NSCLBP)(近 90%)。目前还没有完全治愈慢性腰背痛的疗法。阿育吠陀是印度的传统医学体系之一,在东南亚国家很普遍。尽管阿育吠陀疗法(口服药物、程序性治疗或综合疗法)被广泛用于治疗这种病症,但在治疗的层次上却存在模糊不清的地方。本综述计划比较所有可用的阿育吠陀治疗 NSCLBP 的方法对所有年龄组患者的疗效和安全性。方法本综述将根据系统综述和荟萃分析首选报告项目(PRISMA)和网络荟萃分析 PRISMA 扩展项目撰写。电子检索将在 PubMed、Scopus、TRIP、印度医学期刊索引网站、Cochrane 对照试验注册中心、印度临床试验注册中心、AYUSH 研究门户网站、阿育吠陀研究文章数字帮助热线和其他预印本资料库中进行,检索时间从开始至 2024 年 3 月 31 日。将纳入随机对照试验、随机交叉研究、群组随机研究和非随机干预研究(前瞻性队列研究、非随机临床试验)。将使用 ROB-2、ROBINS-I 以及 Cochrane 协作组织推荐的用于交叉研究和群组随机研究的其他修订版偏倚风险工具来评估偏倚风险。为了评估研究结果的可信度,将采用网络荟萃分析的建议分级评估、发展和评价方法。我们将采用叙事方法来综合和报告定性与定量数据,在可行的情况下,我们将使用 STATA 软件进行网络荟萃分析。结论本方案确定了一项研究计划,通过向政策制定者和利益相关者提供阿育吠陀疗法的治疗层次结构,促进推荐治疗 NSCLBP 的进程。
{"title":"Ayurveda interventions for non-specific chronic low back pain— protocol for a systematic review and network meta-analysis","authors":"Ritu Kumari,&nbsp;Mandip Goyal,&nbsp;Kalpesh Panara","doi":"10.1016/j.eujim.2024.102413","DOIUrl":"10.1016/j.eujim.2024.102413","url":null,"abstract":"<div><h3>Introduction</h3><div>Low back pain (570 million prevalent cases worldwide) is the main contributor to the overall burden of musculoskeletal conditions. The most common form of low back pain is non-specific low back pain (NSCLBP) (almost 90 %). There are no treatments that completely cure chronic low back pain. Ayurveda is one of the traditional systems of Indian medicine commonly practiced in Southeast Asian countries. Even though Ayurveda interventions (oral medication or procedure-based treatment or combined therapy) are practiced widely for this condition, there is ambiguity about the hierarchy of treatment. The present review has been planned to compare all the available Ayurveda treatment modalities for NSCLBP in terms of efficacy, and safety, in all the age groups of patients.</div></div><div><h3>Methods</h3><div>This review will be written in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the PRISMA extension for network meta-analyses. Electronic searches will be carried out in PubMed, Scopus, TRIP, Website of Indexing of Indian Medical Journals, the Cochrane Register for Controlled Trials, The Clinical Trials Registry- India, AYUSH research portal, and Digital Helpline for Ayurveda Research Articles, and other pre-print repositories since its inception till 31st March 2024. Randomized controlled trials, randomized cross-over studies, cluster-randomized studies, and nonrandomized studies of interventions (prospective cohort studies, non-randomized clinical trials) will be included. The risk of bias will be assessed with ROB-2, ROBINS-I, and other revised risk of bias tools for cross-over studies and cluster randomised studies recommended by the Cochrane collaboration. To evaluate the credibility of the findings, the Grading of Recommendations Assessment, Development, and Evaluation method for network meta-analysis will be implemented. A narrative approach to synthesize and report qualitative and quantitative data will be used, and where feasible, we will conduct network meta-analyses using STATA software.</div></div><div><h3>Conclusions</h3><div>This protocol defines a plan of the study that would facilitate the process of recommending treatment for NSCLBP, by providing a treatment hierarchy of Ayurvedic treatment to the policymakers and stakeholders.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"72 ","pages":"Article 102413"},"PeriodicalIF":1.9,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142662812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells 眼部用药的代谢组学特征:探索亚致死高剂量柚皮苷对 ARPE-19 细胞代谢的影响
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-19 DOI: 10.1016/j.eujim.2024.102414
Ozan Kaplan , Emine Koç , Seyhan Türk , Tuba Tüylü Küçükkılınç , Zeynep Göktaş , Mustafa Çelebier

Introduction

Naringenin (NRG), a flavanone polyphenol found in citrus fruits, has been increasingly recognized for its potential therapeutic effects in ocular disorders. This study aimed to assess the impact of high-dose NRG on human retinal pigment epithelial cells (ARPE-19) cells through metabolomic analysis.

Methods

Cell viability was evaluated using the thiazolyl blue tetrazolium bromide (MTT) assay, demonstrating non-cytotoxicity at concentrations ranging from 3 to 100 μM within a 24-h exposure period. High-dose (100 μM) NRG was selected for further investigation based on its non-cytotoxic nature. Chromatographic analyses were performed using Liquid Chromatography Quadropole Time-of-Flight Mass Spectrometry (LC-Q-ToF-MS).

Results

Metabolomic analysis revealed subtle metabolic changes, with similar profiles between control and test groups, emphasizing the nuanced effects of NRG. Multivariate analysis, including Principal Component Analysis (PCA), illustrated distinct clustering of control and test groups, indicating consistent metabolic adjustments within each group. Despite maintaining cell viability, stress responses were identified in ARPE-19 cells, as evidenced by reduced glucose-6-phosphate levels and alterations in pyrimidine/purine pathways. This highlights the importance of exploring cellular responses using metabolomics beyond traditional viability metrics.

Conclusion

In the broader context, this study contributes data on the interplay between NRG and retinal pigmented epithelial. As NRG is utilized in routine ocular applications, particularly as an eye drop, our findings suggest careful dosage selection, considering both non-irritability and subtle metabolic changes. Further research is needed to refine dosage strategies and comprehensively assess the safety profile of NRG in ocular applications.
导言柚皮苷(NRG)是一种存在于柑橘类水果中的黄烷酮多酚,其对眼部疾病的潜在治疗作用已被越来越多的人所认识。本研究旨在通过代谢组学分析评估高剂量 NRG 对人类视网膜色素上皮细胞(ARPE-19)的影响。方法使用噻唑基溴化蓝四氮唑(MTT)检测法评估细胞活力,结果表明,在 3 到 100 μM 的浓度范围内,24 小时暴露期内细胞无毒性。高剂量(100 μM)NRG 无细胞毒性,因此被选作进一步研究的对象。采用液相色谱四极飞行时间质谱法(LC-Q-ToF-MS)进行色谱分析。结果代谢组学分析发现了微妙的代谢变化,对照组和试验组之间的代谢谱相似,这强调了 NRG 的细微影响。包括主成分分析(PCA)在内的多变量分析表明,对照组和测试组有明显的聚类,表明每组内的代谢调整是一致的。尽管保持了细胞的活力,但在 ARPE-19 细胞中发现了应激反应,表现为葡萄糖-6-磷酸水平的降低和嘧啶/嘌呤通路的改变。这凸显了利用代谢组学探索细胞反应的重要性,而非传统的存活率指标。 结论在更广泛的背景下,本研究为 NRG 与视网膜色素上皮之间的相互作用提供了数据。由于 NRG 可用于常规眼科应用,特别是作为眼药水使用,我们的研究结果表明,在选择剂量时应谨慎,既要考虑无刺激性,又要考虑微妙的新陈代谢变化。还需要进一步的研究来完善剂量策略,并全面评估 NRG 在眼部应用中的安全性。
{"title":"Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells","authors":"Ozan Kaplan ,&nbsp;Emine Koç ,&nbsp;Seyhan Türk ,&nbsp;Tuba Tüylü Küçükkılınç ,&nbsp;Zeynep Göktaş ,&nbsp;Mustafa Çelebier","doi":"10.1016/j.eujim.2024.102414","DOIUrl":"10.1016/j.eujim.2024.102414","url":null,"abstract":"<div><h3>Introduction</h3><div>Naringenin (NRG), a flavanone polyphenol found in citrus fruits, has been increasingly recognized for its potential therapeutic effects in ocular disorders. This study aimed to assess the impact of high-dose NRG on human retinal pigment epithelial cells (ARPE-19) cells through metabolomic analysis.</div></div><div><h3>Methods</h3><div>Cell viability was evaluated using the thiazolyl blue tetrazolium bromide (MTT) assay, demonstrating non-cytotoxicity at concentrations ranging from 3 to 100 μM within a 24-h exposure period. High-dose (100 μM) NRG was selected for further investigation based on its non-cytotoxic nature. Chromatographic analyses were performed using Liquid Chromatography Quadropole Time-of-Flight Mass Spectrometry (LC-Q-ToF-MS).</div></div><div><h3>Results</h3><div>Metabolomic analysis revealed subtle metabolic changes, with similar profiles between control and test groups, emphasizing the nuanced effects of NRG. Multivariate analysis, including Principal Component Analysis (PCA), illustrated distinct clustering of control and test groups, indicating consistent metabolic adjustments within each group. Despite maintaining cell viability, stress responses were identified in ARPE-19 cells, as evidenced by reduced glucose-6-phosphate levels and alterations in pyrimidine/purine pathways. This highlights the importance of exploring cellular responses using metabolomics beyond traditional viability metrics.</div></div><div><h3>Conclusion</h3><div>In the broader context, this study contributes data on the interplay between NRG and retinal pigmented epithelial. As NRG is utilized in routine ocular applications, particularly as an eye drop, our findings suggest careful dosage selection, considering both non-irritability and subtle metabolic changes. Further research is needed to refine dosage strategies and comprehensively assess the safety profile of NRG in ocular applications.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"72 ","pages":"Article 102414"},"PeriodicalIF":1.9,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142662814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of neuromodulatory effects of Origanum punonense danin essential oil on AMPA receptor function using whole-cell patch-clamp technique 利用全细胞膜片钳技术评估牛至丹宁精油对 AMPA 受体功能的神经调节作用
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-15 DOI: 10.1016/j.eujim.2024.102411
Mohammad Qneibi , Kamal Issa , Amjad Bakhatan , Majde Abu Khaled , Sosana Bdir , Mohammad Bdair , Dana Sandouka , Nidal Jaradat

Introduction

: The quest for natural compounds with neuromodulatory properties has gained significant momentum in neuropharmacology. Among these, Origanum punonense (O. punonense) essential oil (EO) stands out due to its rich bioactive profile, particularly characterized by carvacrol. This study aimed to elucidate the effects of O. punonense EO on α-amino-3‑hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR), crucial synaptic plasticity, and cognitive function mediators.

Methods

: Leaves of O. punonense were collected along the Dead Sea coast in Jericho. After washing, it was dried in the shade for 15 days and ground. Essential oil was extracted using a microwave-ultrasonic method, with ultrasonic waves to enhance extraction. Using whole-cell patch-clamp techniques, we studied the effects of O. punonense EO on AMPAR kinetics in HEK293t cells transfected with homomeric and heteromeric subunits.

Results

: O. punonense EO significantly reduced AMPAR's whole-cell currents, indicating a targeted modulation of synaptic responses. Oil administration inhibited the currents for glutamate receptor subunits GluA1 (reduced from 885±58 pA to 342±20 pA), GluA1/2 (from 627±77 pA to 209±36 pA), GluA2 (from 1125±112 pA to 256±37 pA), and GluA2/3 (from 474±79 pA to 125±31 pA). The EO decreased the desensitization rate significantly for GluA2 and GluA2/3 (p < 0.01) and for GluA1/2 (p < 0.05), except for GluA1. In addition, the EO increased the deactivation rate significantly for GluA2 and GluA2/3 (p < 0.01) and for GluA1/2 (p < 0.05), with no effect observed on GluA1.

Conclusions

: This study highlights the possible properties of O. punonense EO and suggests future research to understand its medicinal benefits in neurodegenerative diseases.
简介:在神经药理学领域,对具有神经调节特性的天然化合物的探索已取得了显著的进展。其中,牛至(Origanum punonense,O. punonense)精油(EO)因其丰富的生物活性成分(尤其是香芹酚)而脱颖而出。本研究旨在阐明牛至精油对α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPAR)、重要的突触可塑性和认知功能介质的影响:方法:在杰里科的死海沿岸采集 O. punonense 的叶子。方法:在杰里科死海沿岸采集 O punonense 的叶子,洗净后在阴凉处晾晒 15 天,然后研磨。采用微波-超声波法提取精油,并用超声波增强提取效果。我们使用全细胞膜片钳技术,研究了 O. punonense EO 对转染同源亚基和异源亚基的 HEK293t 细胞中 AMPAR 动力学的影响:结果:O. punonense 环氧乙烷能显著降低 AMPAR 的全细胞电流,这表明它能有针对性地调节突触反应。给油可抑制谷氨酸受体亚基 GluA1(从 885±58 pA 降至 342±20 pA)、GluA1/2(从 627±77 pA 降至 209±36 pA)、GluA2(从 1125±112 pA 降至 256±37 pA)和 GluA2/3(从 474±79 pA 降至 125±31 pA)的电流。除 GluA1 外,环氧乙烷显著降低了 GluA2 和 GluA2/3 的脱敏率(p < 0.01)以及 GluA1/2 的脱敏率(p < 0.05)。此外,环氧乙烷还显著增加了 GluA2 和 GluA2/3 的失活率(p < 0.01)以及 GluA1/2 的失活率(p < 0.05),但对 GluA1 没有影响:本研究强调了O. punonense环氧乙烷可能具有的特性,并建议今后开展研究,以了解其在神经退行性疾病中的药用价值。
{"title":"Assessment of neuromodulatory effects of Origanum punonense danin essential oil on AMPA receptor function using whole-cell patch-clamp technique","authors":"Mohammad Qneibi ,&nbsp;Kamal Issa ,&nbsp;Amjad Bakhatan ,&nbsp;Majde Abu Khaled ,&nbsp;Sosana Bdir ,&nbsp;Mohammad Bdair ,&nbsp;Dana Sandouka ,&nbsp;Nidal Jaradat","doi":"10.1016/j.eujim.2024.102411","DOIUrl":"10.1016/j.eujim.2024.102411","url":null,"abstract":"<div><h3>Introduction</h3><div>: The quest for natural compounds with neuromodulatory properties has gained significant momentum in neuropharmacology. Among these, <em>Origanum punonense (O. punonense)</em> essential oil (EO) stands out due to its rich bioactive profile, particularly characterized by carvacrol. This study aimed to elucidate the effects of <em>O. punonense</em> EO on α-amino-3‑hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR), crucial synaptic plasticity, and cognitive function mediators.</div></div><div><h3>Methods</h3><div>: Leaves of <em>O. punonense</em> were collected along the Dead Sea coast in Jericho. After washing, it was dried in the shade for 15 days and ground. Essential oil was extracted using a microwave-ultrasonic method, with ultrasonic waves to enhance extraction. Using whole-cell patch-clamp techniques, we studied the effects of <em>O. punonense EO</em> on AMPAR kinetics in HEK293t cells transfected with homomeric and heteromeric subunits.</div></div><div><h3>Results</h3><div>: <em>O. punonense</em> EO significantly reduced AMPAR's whole-cell currents, indicating a targeted modulation of synaptic responses. Oil administration inhibited the currents for glutamate receptor subunits GluA1 (reduced from 885±58 pA to 342±20 pA), GluA1/2 (from 627±77 pA to 209±36 pA), GluA2 (from 1125±112 pA to 256±37 pA), and GluA2/3 (from 474±79 pA to 125±31 pA). The EO decreased the desensitization rate significantly for GluA2 and GluA2/3 (<em>p</em> &lt; 0.01) and for GluA1/2 (<em>p</em> &lt; 0.05), except for GluA1. In addition, the EO increased the deactivation rate significantly for GluA2 and GluA2/3 (<em>p</em> &lt; 0.01) and for GluA1/2 (<em>p</em> &lt; 0.05), with no effect observed on GluA1.</div></div><div><h3>Conclusions</h3><div>: This study highlights the possible properties of <em>O. punonense</em> EO and suggests future research to understand its medicinal benefits in neurodegenerative diseases.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"72 ","pages":"Article 102411"},"PeriodicalIF":1.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142527124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The dose-effect relationship of acupuncture in the treatment of functional gastrointestinal disorders: A meta-regression of randomized controlled trials 针灸治疗功能性胃肠功能紊乱的剂量效应关系:随机对照试验的元回归
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-01 DOI: 10.1016/j.eujim.2024.102406
Siyao Gong, Xin Yu, Jiao Yang, Dan Huang, Shuguang Yu, Sha Yang

Introduction

The efficacy of acupuncture in treating functional gastrointestinal disorders (FGIDs) has been widely acknowledged. However, the dose-response relationship between acupuncture frequency and FGIDs remains uncertain. This review aimed to explore the relationship between the number of acupuncture sessions and the efficacy of acupuncture for FGIDs.

Methods

Seven major databases were searched from their inception to April 25, 2023. Literature screening, risk of bias assessment, and data extraction were performed by two reviewers independently. The quality of included randomized controlled trials (RCTs) was assessed using the Cochrane bias risk tool and Jadad score. The dose-effect relationship between acupuncture sessions and the clinical response rate in patients with FGIDs was investigated by using the cubic spline limited nonlinear meta-regression method in statal5.1. Before the review, we conducted the PROSPERO registration (CRD42022344699).

Results

Our analysis included 100 studies on acupuncture treatment of FGIDs, encompassing 8,589 participants. The meta-analysis of the dose-response relationship indicated that acupuncture could improve clinical symptoms and clinical response in patients with FGIDs to some extent. The clinical response rate increased with the number of acupuncture sessions in the range of ten to twenty sessions, with the odds ratio (OR) value rising from 1.05 (95 % CI: 0.89, 1.21) to 1.38 (95 % CI: 1.22,1.53). The peak of clinical response rate was observed at 24 acupuncture sessions (OR = 1.40; 95 % CI: 1.25, 1.55), representing a 40 % increase in OR. Compared with 24 sessions, the clinical response rate decreased after 56 sessions (OR = 1.22; 95 % CI: 0.64, 1.81).

Conclusion

There is a dose-response relationship between the number of acupuncture sessions and the clinical response in individuals with FGIDs. Twenty-four acupuncture treatments correlate with the optimal clinical response.
引言 针灸治疗功能性胃肠病(FGIDs)的疗效已得到广泛认可。然而,针灸次数与 FGIDs 之间的剂量-反应关系仍不确定。本综述旨在探讨针灸次数与针灸治疗 FGIDs 疗效之间的关系。文献筛选、偏倚风险评估和数据提取由两名审稿人独立完成。使用 Cochrane 偏倚风险工具和 Jadad 评分评估了纳入的随机对照试验(RCT)的质量。我们使用 statal5.1 中的立方样条有限非线性元回归方法研究了针灸疗程与 FGID 患者临床反应率之间的剂量效应关系。结果我们的分析纳入了 100 项针灸治疗 FGIDs 的研究,涉及 8589 名参与者。剂量-反应关系的荟萃分析表明,针灸可在一定程度上改善 FGIDs 患者的临床症状和临床反应。临床反应率随着针灸次数的增加而增加,在十次至二十次的范围内,几率比(OR)值从 1.05(95 % CI:0.89,1.21)上升到 1.38(95 % CI:1.22,1.53)。临床反应率的峰值出现在针灸 24 次时(OR = 1.40;95 % CI:1.25, 1.55),OR 值增加了 40%。结论针灸次数与 FGIDs 患者的临床反应之间存在剂量-反应关系。24次针灸治疗与最佳临床反应相关。
{"title":"The dose-effect relationship of acupuncture in the treatment of functional gastrointestinal disorders: A meta-regression of randomized controlled trials","authors":"Siyao Gong,&nbsp;Xin Yu,&nbsp;Jiao Yang,&nbsp;Dan Huang,&nbsp;Shuguang Yu,&nbsp;Sha Yang","doi":"10.1016/j.eujim.2024.102406","DOIUrl":"10.1016/j.eujim.2024.102406","url":null,"abstract":"<div><h3>Introduction</h3><div>The efficacy of acupuncture in treating functional gastrointestinal disorders (FGIDs) has been widely acknowledged. However, the dose-response relationship between acupuncture frequency and FGIDs remains uncertain. This review aimed to explore the relationship between the number of acupuncture sessions and the efficacy of acupuncture for FGIDs.</div></div><div><h3>Methods</h3><div>Seven major databases were searched from their inception to April 25, 2023. Literature screening, risk of bias assessment, and data extraction were performed by two reviewers independently. The quality of included randomized controlled trials (RCTs) was assessed using the Cochrane bias risk tool and Jadad score. The dose-effect relationship between acupuncture sessions and the clinical response rate in patients with FGIDs was investigated by using the cubic spline limited nonlinear meta-regression method in statal5.1. Before the review, we conducted the PROSPERO registration (CRD42022344699).</div></div><div><h3>Results</h3><div>Our analysis included 100 studies on acupuncture treatment of FGIDs, encompassing 8,589 participants. The meta-analysis of the dose-response relationship indicated that acupuncture could improve clinical symptoms and clinical response in patients with FGIDs to some extent. The clinical response rate increased with the number of acupuncture sessions in the range of ten to twenty sessions, with the odds ratio (OR) value rising from 1.05 (95 % CI: 0.89, 1.21) to 1.38 (95 % CI: 1.22,1.53). The peak of clinical response rate was observed at 24 acupuncture sessions (OR = 1.40; 95 % CI: 1.25, 1.55), representing a 40 % increase in OR. Compared with 24 sessions, the clinical response rate decreased after 56 sessions (OR = 1.22; 95 % CI: 0.64, 1.81).</div></div><div><h3>Conclusion</h3><div>There is a dose-response relationship between the number of acupuncture sessions and the clinical response in individuals with FGIDs. Twenty-four acupuncture treatments correlate with the optimal clinical response.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"71 ","pages":"Article 102406"},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antioxidant and anti-urease activities of Cardamine bulbifera: Insights from molecular docking and density functional theory studies 灯心草的抗氧化和抗尿素酶活性:分子对接和密度泛函理论研究的启示
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-01 DOI: 10.1016/j.eujim.2024.102410
Emine İncilay Torunoğlu , Erdi Can Aytar , Betül Aydın , Alper Durmaz

Introduction

Cardamine bulbifera (L.) Crantz, commonly known as “Asian bittercress”, is a plant species widely distributed across Asia. It belongs to the Brassicaceae and has been traditionally used in medicinal applications. This study investigates the phytochemical composition, phenolic content, antioxidant properties, and anti-urease activity of C. bulbifera.

Methods

In this study, the aerial parts of the C. bulbifera were collected. The total polyphenol content of the extracts was determined using spectrophotometric methods, and its antioxidant and anti-urease activities were assessed. The chemical composition was characterised using gas chromatography-mass spectroscopic (GC-MS) analysis. Additionally, molecular docking studies explored potential interactions between the identified compounds and Helicobacter pylori CagA oncoprotein. Furthermore, Density Functional Theory (DFT) analysis provided valuable insights into the electronic properties of the main compounds.

Result

The total phenolic content of C. bulbifera extract was 225 ± 0.02 mg GAE/g extract DW, and the total flavonoid content was 62.64 ± 3.27 mg QE/g extract DW. The 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) assay revealed an IC50 value of 1.01 ± 0.04 mg/mL, indicating significant antioxidant activity. The IC50 value for anti-urease activity was determined to be 2.74 ± 0.03 µg/mL, suggesting potent inhibition of urease enzyme activity. GC-MS analysis identified 15 bioactive compounds in the extract. Molecular docking studies highlighted Phenol, 3,5-bis(1,1-dimethylethyl) and 1-dodecanol as compounds with the highest binding affinity for the H. pylori CagA oncoprotein, suggesting potential therapeutic implications against H. pylori-related cancers. Additionally, DFT analysis emphasised these compounds' electronic properties and chemical reactivities, indicating their potential role in future pharmaceutical developments.

Conclusion

C. bulbifera exhibits rich phenolic and flavonoid content and significant antioxidant and intense urease inhibition activities. These findings suggest that C. bulbifera may offer potential therapeutic options for conditions related to H. pylori infections, including cancer. Further research is needed to explore its mechanisms of action and clinical applications in more detail.
导言:Cardamine bulbifera (L.) Crantz,俗称 "亚洲苦菜",是一种广泛分布于亚洲的植物物种。它属于十字花科(Brassicaceae),传统上一直被用于药用。本研究调查了 C. bulbifera 的植物化学成分、酚含量、抗氧化性和抗尿酸酶活性。采用分光光度法测定了提取物中的总多酚含量,并评估了其抗氧化性和抗尿素酶活性。采用气相色谱-质谱(GC-MS)分析法对化学成分进行了表征。此外,分子对接研究还探讨了已鉴定化合物与幽门螺旋杆菌 CagA 癌蛋白之间的潜在相互作用。此外,密度泛函理论(DFT)分析为了解主要化合物的电子特性提供了有价值的见解。 结果球茎花提取物的总酚含量为 225 ± 0.02 毫克 GAE/克提取物 DW,总黄酮含量为 62.64 ± 3.27 毫克 QE/克提取物 DW。2,2-二苯基-1-苦基肼(DPPH)测定的 IC50 值为 1.01 ± 0.04 mg/mL,表明其具有显著的抗氧化活性。抗脲酶活性的 IC50 值为 2.74 ± 0.03 µg/mL,表明对脲酶活性有很强的抑制作用。GC-MS 分析确定了提取物中的 15 种生物活性化合物。分子对接研究表明,苯酚、3,5-双(1,1-二甲基乙基)和 1-十二醇是与幽门螺杆菌 CagA 肿瘤蛋白结合亲和力最高的化合物,这表明它们对幽门螺杆菌相关癌症具有潜在的治疗意义。此外,DFT 分析强调了这些化合物的电子特性和化学反应活性,表明它们在未来的药物开发中具有潜在作用。这些研究结果表明,C. bulbifera 可为幽门螺杆菌感染相关疾病(包括癌症)提供潜在的治疗方案。要更详细地探索其作用机制和临床应用,还需要进一步的研究。
{"title":"Antioxidant and anti-urease activities of Cardamine bulbifera: Insights from molecular docking and density functional theory studies","authors":"Emine İncilay Torunoğlu ,&nbsp;Erdi Can Aytar ,&nbsp;Betül Aydın ,&nbsp;Alper Durmaz","doi":"10.1016/j.eujim.2024.102410","DOIUrl":"10.1016/j.eujim.2024.102410","url":null,"abstract":"<div><h3>Introduction</h3><div><em>Cardamine bulbifera</em> (L.) Crantz, commonly known as “Asian bittercress”, is a plant species widely distributed across Asia. It belongs to the Brassicaceae and has been traditionally used in medicinal applications. This study investigates the phytochemical composition, phenolic content, antioxidant properties, and anti-urease activity of <em>C. bulbifera.</em></div></div><div><h3>Methods</h3><div>In this study, the aerial parts of the <em>C. bulbifera</em> were collected. The total polyphenol content of the extracts was determined using spectrophotometric methods, and its antioxidant and anti-urease activities were assessed. The chemical composition was characterised using gas chromatography-mass spectroscopic (GC-MS) analysis. Additionally, molecular docking studies explored potential interactions between the identified compounds and <em>Helicobacter pylori</em> CagA oncoprotein. Furthermore, Density Functional Theory (DFT) analysis provided valuable insights into the electronic properties of the main compounds.</div></div><div><h3>Result</h3><div>The total phenolic content of <em>C. bulbifera</em> extract was 225 ± 0.02 mg GAE/g extract DW, and the total flavonoid content was 62.64 ± 3.27 mg QE/g extract DW. The 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) assay revealed an IC<sub>50</sub> value of 1.01 ± 0.04 mg/mL, indicating significant antioxidant activity. The IC<sub>50</sub> value for anti-urease activity was determined to be 2.74 ± 0.03 µg/mL, suggesting potent inhibition of urease enzyme activity. GC-MS analysis identified 15 bioactive compounds in the extract. Molecular docking studies highlighted Phenol, 3,5-bis(1,1-dimethylethyl) and 1-dodecanol as compounds with the highest binding affinity for the <em>H. pylori</em> CagA oncoprotein, suggesting potential therapeutic implications against <em>H. pylori</em>-related cancers. Additionally, DFT analysis emphasised these compounds' electronic properties and chemical reactivities, indicating their potential role in future pharmaceutical developments.</div></div><div><h3>Conclusion</h3><div><em>C. bulbifera</em> exhibits rich phenolic and flavonoid content and significant antioxidant and intense urease inhibition activities. These findings suggest that <em>C. bulbifera</em> may offer potential therapeutic options for conditions related to <em>H. pylori</em> infections, including cancer. Further research is needed to explore its mechanisms of action and clinical applications in more detail.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"71 ","pages":"Article 102410"},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should eighteen incompatibilities be used? A systematic review and meta-analysis of the analgesic effect of pinellia and aconitum used externally for cancer pain 是否应该使用十八种不相容药物?外用针叶和乌头治疗癌痛的镇痛效果的系统综述和荟萃分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-01 DOI: 10.1016/j.eujim.2024.102407
Can Cao , Xiaoqing Liu , Meijing Wu , Xiangnan Xu , Wenyong Liao , Xiao Dong , Yi Tian , Ying Zhang , Gansheng Zhong

Introduction

Many clinical formulas containing the couplet Chinese medicines pinellia and aconitum (CMPA) have been recognized and demonstrated analgesic efficacy. However, CMPA belongs to the "eighteen incompatibilities" of traditional Chinese medicine theory, which is considered prohibited and dangerous by some medical practitioners. Whether CMPA can truly be used safely and without concern in the clinic urgently requires a more cohesive evaluation of the evidence. This review aims to evaluate the effectiveness and safety of CMPA for external use in the treatment of cancer pain.

Methods

We searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, VIP, and Sinomed databases to collect randomized controlled trials (RCTs) comparing CMPA with conventional medicines for the treatment of cancer pain from their inception to December 31, 2023. Meta-analysis was conducted using RevMan 5.4 software. The modified Cochrane risk of bias tool was used to assess the quality of the included studies, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence profile was constructed to illustrate the certainty of evidence.

Results

A total of 1083 patients were enrolled in 14 RCTs. The results of the meta-analysis showed that the numerical rating scale (NRS) pain score [MD=-0.84, 95 % CI (-1.21, -0.47), P < 0.00001, moderate certainty], duration of continuous analgesia [MD=1.45 h, 95 % CI (1.13, 1.77), P < 0.00001, low certainty], and Karnofsky performance status (KPS) quality of life score [MD=7.25, 95 % CI (5.01, 9.48), P < 0.00001, low certainty] of patients after external administration of CMPA-containing prescriptions in combination with conventional medicine therapy were better than those with the conventional medicine therapy. The incidence of total adverse reactions [RR=0.69, 95 % CI (0.58, 0.83), P < 0.0001, moderate certainty] and constipation [RR=0.43, 95 % CI (0.19, 0.97), P = 0.04, moderate certainty] of patients after external administration of CMPA-containing prescriptions in combination with conventional medicine therapy were lower than those with the conventional medicine therapy. No statistically significant differences were found regarding the effectiveness or safety of CMPA-containing prescriptions compared to conventional medicine therapy (low or very low certainty evidence).

Conclusion

The external use of CMPA-containing prescriptions, when combined with conventional medicine therapy, is safer and more effective for cancer pain than conventional medicine therapy. However, higher-level evidence is still warranted.

Review registration

PROSPERO registration number: CRD42023400792.
引言 含有中药松针和乌头(CMPA)的许多临床方剂已得到认可,并显示出镇痛疗效。然而,CMPA 属于中医理论中的 "十八反",被一些医家视为禁药和危险药。CMPA 能否真正安全无忧地应用于临床,迫切需要对证据进行更全面的评估。方法我们检索了PubMed、Embase、Cochrane Library、CNKI、万方、VIP和Sinomed数据库,收集了从开始到2023年12月31日期间比较CMPA与常规药物治疗癌痛的随机对照试验(RCT)。使用RevMan 5.4软件进行了荟萃分析。使用修改后的 Cochrane 偏倚风险工具评估纳入研究的质量,并构建了建议评估、发展和评价分级(GRADE)证据概况,以说明证据的确定性。荟萃分析结果显示,数字评分量表(NRS)疼痛评分[MD=-0.84,95 % CI (-1.21, -0.47),P <0.00001,中等确定性]、持续镇痛时间[MD=1.45 h,95 % CI (1.13, 1.77),P <0.00001,低确定性]和卡诺夫斯基表现状态(KPS)生活质量评分[MD=7.25,95 % CI (5.01,9.48),P < 0.00001,低确定性]。外用含 CMPA 处方联合常规药物治疗后,患者总不良反应[RR=0.69,95 % CI (0.58,0.83),P < 0.0001,中等确定性]和便秘[RR=0.43,95 % CI (0.19,0.97),P = 0.04,中等确定性]的发生率低于常规药物治疗。结论与传统药物疗法相比,外用含 CMPA 处方治疗癌痛更安全、更有效。综述注册PROSPERO注册号:CRD42023400792。
{"title":"Should eighteen incompatibilities be used? A systematic review and meta-analysis of the analgesic effect of pinellia and aconitum used externally for cancer pain","authors":"Can Cao ,&nbsp;Xiaoqing Liu ,&nbsp;Meijing Wu ,&nbsp;Xiangnan Xu ,&nbsp;Wenyong Liao ,&nbsp;Xiao Dong ,&nbsp;Yi Tian ,&nbsp;Ying Zhang ,&nbsp;Gansheng Zhong","doi":"10.1016/j.eujim.2024.102407","DOIUrl":"10.1016/j.eujim.2024.102407","url":null,"abstract":"<div><h3>Introduction</h3><div>Many clinical formulas containing the couplet Chinese medicines pinellia and aconitum (CMPA) have been recognized and demonstrated analgesic efficacy. However, CMPA belongs to the \"eighteen incompatibilities\" of traditional Chinese medicine theory, which is considered prohibited and dangerous by some medical practitioners. Whether CMPA can truly be used safely and without concern in the clinic urgently requires a more cohesive evaluation of the evidence. This review aims to evaluate the effectiveness and safety of CMPA for external use in the treatment of cancer pain.</div></div><div><h3>Methods</h3><div>We searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, VIP, and Sinomed databases to collect randomized controlled trials (RCTs) comparing CMPA with conventional medicines for the treatment of cancer pain from their inception to December 31, 2023. Meta-analysis was conducted using RevMan 5.4 software. The modified Cochrane risk of bias tool was used to assess the quality of the included studies, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence profile was constructed to illustrate the certainty of evidence.</div></div><div><h3>Results</h3><div>A total of 1083 patients were enrolled in 14 RCTs. The results of the meta-analysis showed that the numerical rating scale (NRS) pain score [MD=-0.84, 95 % CI (-1.21, -0.47), <em>P</em> &lt; 0.00001, moderate certainty], duration of continuous analgesia [MD=1.45 h, 95 % CI (1.13, 1.77), <em>P</em> &lt; 0.00001, low certainty], and Karnofsky performance status (KPS) quality of life score [MD=7.25, 95 % CI (5.01, 9.48), <em>P</em> &lt; 0.00001, low certainty] of patients after external administration of CMPA-containing prescriptions in combination with conventional medicine therapy were better than those with the conventional medicine therapy. The incidence of total adverse reactions [RR=0.69, 95 % CI (0.58, 0.83), <em>P</em> &lt; 0.0001, moderate certainty] and constipation [RR=0.43, 95 % CI (0.19, 0.97), <em>P</em> = 0.04, moderate certainty] of patients after external administration of CMPA-containing prescriptions in combination with conventional medicine therapy were lower than those with the conventional medicine therapy. No statistically significant differences were found regarding the effectiveness or safety of CMPA-containing prescriptions compared to conventional medicine therapy (low or very low certainty evidence).</div></div><div><h3>Conclusion</h3><div>The external use of CMPA-containing prescriptions, when combined with conventional medicine therapy, is safer and more effective for cancer pain than conventional medicine therapy. However, higher-level evidence is still warranted.</div></div><div><h3>Review registration</h3><div>PROSPERO registration number: CRD42023400792.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"71 ","pages":"Article 102407"},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142415980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pueraria lobata radix (Ge Gen)-containing traditional Chinese medicine prescriptions for the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis 含葛根的中药处方治疗非酒精性脂肪肝:系统回顾和荟萃分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-01 DOI: 10.1016/j.eujim.2024.102405
Haoyu Wang , Huilin Liu , Xiangmin Deng , Ping Luo , Yaqi Tian , Rui Zhang , Gaochuan Zhang , Xunxun Yuan , Xu Zhou

Introduction

This study aimed to systematically evaluate the effectiveness and safety of Pueraria lobata radix (Chinese name: Ge Gen)-containing prescriptions (GGPs) for the treatment of nonalcoholic fatty liver disease (NAFLD).

Methods

Seven databases were searched for randomized controlled trials (RCTs) comparing the effectiveness of GGPs plus basic therapies (Western medicines or lifestyle interventions) versus the same basic therapies in patients with NAFLD. The primary outcomes were liver function indicators, and the secondary outcomes included metabolism indicators, severity of symptoms, and incidence of adverse events. The effects were measured as weighted mean differences (WMDs), standard mean differences (SMDs), and 95 % confidence intervals (CIs).

Results

Eighteen RCTs involving 1,991 patients were included. Meta-analysis results showed that compared to the control group, the GGP group had a significant improvement in liver function (aspartate aminotransferase: WMD -9.60 U/L, 95 % CI -14.96 to -4.25; alanine aminotransferase:6.30 U/L, 95 % CI -9.57 to -3.02; gamma-glutamyl transferase:6.35 U/L, 95 % CI -10.44 to -2.25), blood lipid levels (total cholesterol: WMD -0.68 mmol/L, 95 % CI -0.88 to -0.49; triglycerides:0.61 mmol/L, 95 % CI -0.84 to -0.38; low-density lipoprotein cholesterol:0.42 mmol/L, 95 % CI -0.56 to -0.27; high-density lipoprotein cholesterol: 0.34 mmol/L, 95 % CI 0.21 to 0.47), body mass index (WMD -0.79 kg/m2, 95 % CI -1.38 to -0.19), blood glucose levels (fasting blood glucose: WMD -1.03 mmol/L, 95 % CI -1.52 to -0.44; 2-hour postprandial blood glucose:1.06 mmol/L, 95 % CI -1.68 to -0.28; glycosylated hemoglobin:0.56 %, 95 % CI -0.85 to -0.28; homeostatic model assessment of insulin resistance:0.85 mmol/L, 95 % CI -1.15 to -0.56; fasting insulin:2.34 mmol/L, 95 % CI -3.14 to -1.55), and symptom severity scores (SMD -1.91, 95 % CI -2.48 to -1.34). The GGP group reported six mild adverse events, including diarrhea, nausea, and stomach discomfort.

Conclusion

GGPs, as an adjunct therapy for NAFLD, may improve liver function, metabolic parameters, and clinical symptoms, with good safety. However, the quality of evidence was moderate-to-very low owing to the presence of a moderate-to-high risk of bias and significant heterogeneity.
方法检索了七个数据库,比较了葛根汤加基本疗法(西药或生活方式干预)与相同基本疗法对非酒精性脂肪肝患者的疗效。主要结果是肝功能指标,次要结果包括代谢指标、症状严重程度和不良事件发生率。疗效以加权平均差(WMDs)、标准平均差(SMDs)和95%置信区间(CIs)来衡量。元分析结果显示,与对照组相比,GGP 组的肝功能有显著改善(天门冬氨酸氨基转移酶:WMD -9.60 U/L):WMD -9.60 U/L,95 % CI -14.96 to -4.25;丙氨酸氨基转移酶:6.30 U/L,95 % CI -9.57 to -3.02;γ-谷氨酰转移酶:6.35 U/L,95 % CI -10.44 to -2.25)、血脂水平(总胆固醇:WMD -0.68 mmol/L,95 % CI -0.88 to -0.49;甘油三酯:0.61 mmol/L,95 % CI -0.84 至 -0.38;低密度脂蛋白胆固醇:0.42 mmol/L,95 % CI -0.56 至 -0.27;高密度脂蛋白胆固醇:0.34 mmol/L,95 % CI 0.21 至 0.47)、体重指数(WMD -0.79 kg/m2,95 % CI -1.38 至 -0.19)、血糖水平(空腹血糖:WMD -1.03 mmol/L,95 % CI -1.52 to -0.44;餐后 2 小时血糖:1.06 mmol/L,95 % CI -1.68 to -0.28;糖化血红蛋白:0.56 %,95 % CI -0.85 to -0.28;胰岛素抵抗稳态模型评估:0.85 mmol/L,95 % CI -1.15 至 -0.56;空腹胰岛素:2.34 mmol/L,95 % CI -3.14 至 -1.55)和症状严重程度评分(SMD -1.91,95 % CI -2.48 至 -1.34)。结论GGP作为非酒精性脂肪肝的辅助疗法,可改善肝功能、代谢指标和临床症状,安全性良好。然而,由于存在中度到高度的偏倚风险和显著的异质性,证据质量为中度到极低。
{"title":"Pueraria lobata radix (Ge Gen)-containing traditional Chinese medicine prescriptions for the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis","authors":"Haoyu Wang ,&nbsp;Huilin Liu ,&nbsp;Xiangmin Deng ,&nbsp;Ping Luo ,&nbsp;Yaqi Tian ,&nbsp;Rui Zhang ,&nbsp;Gaochuan Zhang ,&nbsp;Xunxun Yuan ,&nbsp;Xu Zhou","doi":"10.1016/j.eujim.2024.102405","DOIUrl":"10.1016/j.eujim.2024.102405","url":null,"abstract":"<div><h3>Introduction</h3><div>This study aimed to systematically evaluate the effectiveness and safety of <em>Pueraria lobata radix</em> (Chinese name: Ge Gen)-containing prescriptions (GGPs) for the treatment of nonalcoholic fatty liver disease (NAFLD).</div></div><div><h3>Methods</h3><div>Seven databases were searched for randomized controlled trials (RCTs) comparing the effectiveness of GGPs plus basic therapies (Western medicines or lifestyle interventions) versus the same basic therapies in patients with NAFLD. The primary outcomes were liver function indicators, and the secondary outcomes included metabolism indicators, severity of symptoms, and incidence of adverse events. The effects were measured as weighted mean differences (WMDs), standard mean differences (SMDs), and 95 % confidence intervals (CIs).</div></div><div><h3>Results</h3><div>Eighteen RCTs involving 1,991 patients were included. Meta-analysis results showed that compared to the control group, the GGP group had a significant improvement in liver function (aspartate aminotransferase: WMD -9.60 U/L, 95 % CI -14.96 to -4.25; alanine aminotransferase:6.30 U/L, 95 % CI -9.57 to -3.02; gamma-glutamyl transferase:6.35 U/L, 95 % CI -10.44 to -2.25), blood lipid levels (total cholesterol: WMD -0.68 mmol/L, 95 % CI -0.88 to -0.49; triglycerides:0.61 mmol/L, 95 % CI -0.84 to -0.38; low-density lipoprotein cholesterol:0.42 mmol/L, 95 % CI -0.56 to -0.27; high-density lipoprotein cholesterol: 0.34 mmol/L, 95 % CI 0.21 to 0.47), body mass index (WMD -0.79 kg/m<sup>2</sup>, 95 % CI -1.38 to -0.19), blood glucose levels (fasting blood glucose: WMD -1.03 mmol/L, 95 % CI -1.52 to -0.44; 2-hour postprandial blood glucose:1.06 mmol/L, 95 % CI -1.68 to -0.28; glycosylated hemoglobin:0.56 %, 95 % CI -0.85 to -0.28; homeostatic model assessment of insulin resistance:0.85 mmol/L, 95 % CI -1.15 to -0.56; fasting insulin:2.34 mmol/L, 95 % CI -3.14 to -1.55), and symptom severity scores (SMD -1.91, 95 % CI -2.48 to -1.34). The GGP group reported six mild adverse events, including diarrhea, nausea, and stomach discomfort.</div></div><div><h3>Conclusion</h3><div>GGPs, as an adjunct therapy for NAFLD, may improve liver function, metabolic parameters, and clinical symptoms, with good safety. However, the quality of evidence was moderate-to-very low owing to the presence of a moderate-to-high risk of bias and significant heterogeneity.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"71 ","pages":"Article 102405"},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142415979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DOTTs-Database of Therapeutic Plants against Tuberculosis: Rationalizing traditional medicine for therapeutic applications DOTTs--结核病治疗植物数据库:合理利用传统医药进行治疗
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-10-01 DOI: 10.1016/j.eujim.2024.102409
Hazarika Risha , Gangar Tarun , Patra Sanjukta

Introduction

Mycobacterium tuberculosis, a highly resistant superbug causing tuberculosis disease (TB), contributes to one of the leading causes of death worldwide. Improved drug regimens and therapeutics have been extensively studied, but still none are proven to be fully effective in eliminating the pathogen or its drug-resistant forms. Therefore, alternative and novel therapeutic approaches to address this problem are needed. Traditional medicine can be vital in managing TB via codified (Ayurveda, Siddha, Unani) and uncodified systems (folk medicine). In recent years, the utilization of medicinal plants for TB therapy has garnered considerable attention. Identifying underexplored plants utilized as a remedy for TB can aid in developing future treatment strategies. The current study aims to assemble the ethnobotanical literature that provides insight into the undocumented tribal/folk medicinal practices against tuberculosis in one unified platform.

Methods

The medicinal plants with therapeutic properties against tuberculosis were identified manually by screening published literature. The data is represented to the users using a user-friendly web interface developed via the PHP-HTML platform using Bootstrap Cascading Style Sheet (CSS) theme, and the database is managed by MySQL Database Management System (DBMS).

Results

Database of Therapeutic Plants against Tuberculosis (DOTTs) describes the medicinal plants used traditionally in different forms against tuberculosis by various indigenous tribes and communities in India. A total of 100 plants with their local names, taxonomical classification (order and family), tribe, plant part, and formulations, as well as the anti-tubercular attributes, are provided in the database. Additional information about the plants can be retrieved from the external links provided.

Conclusion

The DOTTs database provides the ethnobotanical and ethnopharmacological data of 100 Indian medicinal plants. This database will help the researchers acquire information about the plants that could be beneficial for further evaluation and discovery of potential leads in TB drug discovery. With proper investigation and advancement, it is anticipated that TB could no longer be a serious public health risk.
导言结核分枝杆菌是一种导致结核病(TB)的高度耐药性超级细菌,是造成全球死亡的主要原因之一。人们对改良药物方案和疗法进行了广泛研究,但仍未证明它们能完全有效地消灭病原体或其耐药形式。因此,我们需要其他新颖的治疗方法来解决这一问题。传统医学在通过成文法(阿育吠陀、悉达、尤那尼)和非成文法(民间医学)治疗结核病方面发挥着重要作用。近年来,利用药用植物治疗结核病已引起广泛关注。发现未被充分开发的治疗结核病的植物有助于制定未来的治疗策略。本研究旨在将民族植物学文献汇集到一个统一的平台上,以便深入了解未记载的部落/民间结核病治疗方法。通过使用 Bootstrap 层叠样式表(CSS)主题的 PHP-HTML 平台开发的用户友好型网络界面向用户展示数据,数据库由 MySQL 数据库管理系统(DBMS)管理。数据库中提供了总共 100 种植物的当地名称、分类学分类(目和科)、部落、植物部位、配方以及抗结核属性。结论 DOTTs 数据库提供了 100 种印度药用植物的民族植物学和民族药理学数据。该数据库将帮助研究人员获取有关这些植物的信息,从而有利于进一步评估和发现结核病药物研发的潜在线索。通过适当的调查和研究,结核病有望不再成为严重的公共卫生风险。
{"title":"DOTTs-Database of Therapeutic Plants against Tuberculosis: Rationalizing traditional medicine for therapeutic applications","authors":"Hazarika Risha ,&nbsp;Gangar Tarun ,&nbsp;Patra Sanjukta","doi":"10.1016/j.eujim.2024.102409","DOIUrl":"10.1016/j.eujim.2024.102409","url":null,"abstract":"<div><h3>Introduction</h3><div><em>Mycobacterium tuberculosis,</em> a highly resistant superbug causing tuberculosis disease (TB), contributes to one of the leading causes of death worldwide. Improved drug regimens and therapeutics have been extensively studied, but still none are proven to be fully effective in eliminating the pathogen or its drug-resistant forms. Therefore, alternative and novel therapeutic approaches to address this problem are needed. Traditional medicine can be vital in managing TB via codified (Ayurveda, Siddha, Unani) and uncodified systems (folk medicine). In recent years, the utilization of medicinal plants for TB therapy has garnered considerable attention. Identifying underexplored plants utilized as a remedy for TB can aid in developing future treatment strategies. The current study aims to assemble the ethnobotanical literature that provides insight into the undocumented tribal/folk medicinal practices against tuberculosis in one unified platform.</div></div><div><h3>Methods</h3><div>The medicinal plants with therapeutic properties against tuberculosis were identified manually by screening published literature. The data is represented to the users using a user-friendly web interface developed via the PHP-HTML platform using Bootstrap Cascading Style Sheet (CSS) theme, and the database is managed by MySQL Database Management System (DBMS).</div></div><div><h3>Results</h3><div>Database of Therapeutic Plants against Tuberculosis (DOTTs) describes the medicinal plants used traditionally in different forms against tuberculosis by various indigenous tribes and communities in India. A total of 100 plants with their local names, taxonomical classification (order and family), tribe, plant part, and formulations, as well as the anti-tubercular attributes, are provided in the database. Additional information about the plants can be retrieved from the external links provided.</div></div><div><h3>Conclusion</h3><div>The DOTTs database provides the ethnobotanical and ethnopharmacological data of 100 Indian medicinal plants. This database will help the researchers acquire information about the plants that could be beneficial for further evaluation and discovery of potential leads in TB drug discovery. With proper investigation and advancement, it is anticipated that TB could no longer be a serious public health risk.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"71 ","pages":"Article 102409"},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of music interventions on anxiety, pain, and pregnancy rates in women undergoing fertility treatment before oocyte collection and embryo transfer: Systematic review and meta-analysis of randomized controlled trials 音乐干预对接受生育治疗的妇女在卵细胞采集和胚胎移植前的焦虑、疼痛和怀孕率的影响:随机对照试验的系统回顾和荟萃分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-23 DOI: 10.1016/j.eujim.2024.102408
Mehtap Kızılkaya , Aysu Yıldız Karaahmet , Kerime Derya Beydağ

Introdution

The present review aimed to evaluate the available evidence in the literature on the effect of music interventions on improving outcomes related to anxiety, pain, and pregnancy rates of women undergoing fertility treatment, prior to oocyte collection and embryo transfer.

Method

We searched the following databases from database inception to 2 May 2024, PUBMED, Embase, Web of Science, and the Turkish Academic Network and Information Center (ULAKBIM). Randomized controlled trials (RCT) in Turkish and English languages were included in the screening. Articles were scanned using MeSH-based keywords. The data were analyzed using the Review Manager computer program (Version 5.4.1).

Results

A total of 8 RCTs, including 1634 female patients, were included in our review. Music interventions significantly reduced anxiety scores prior to oocyte collection or fertilization compared to the control group (Standardised Mean Difference (SMD):0.26, 95 % CI:0.39 to 0.13, Z = 3.91, p < 0.0001). Moreover, after the music treatment, there was a significant improvement in the pain score during the procedure (SMD:0.96, 95 % CI:1.72 to -0.20, Z = 2.49, p = 0.01). Although more women in the music interventions group experienced an increase in the clinical pregnancy rate compared to the control group, there was no evidence of an effect on pregnancy rate (SMD:0.14, 95 % CI:2.63 to 2.34, Z = 0.11, p = 0.91).

Conclusion

Music interventions appears to improve anxiety and pain scores in female patients receiving fertility treatment when administered during oocyte collection and fertilization. They may increase the clinical pregnancy rate but this not statistically significant. More research with larger sample sizes is needed to investigate the impact of music interventions on assisted reproductive technology clinical outcomes.
介绍本综述旨在评估文献中关于音乐干预对改善接受生育治疗的妇女在卵细胞采集和胚胎移植前的焦虑、疼痛和妊娠率相关结果的影响的现有证据。方法我们检索了以下数据库(从数据库开始到 2024 年 5 月 2 日):PUBMED、Embase、Web of Science 和土耳其学术网络和信息中心 (ULAKBIM)。筛选包括土耳其语和英语的随机对照试验(RCT)。文章采用基于 MeSH 的关键词进行扫描。结果共有 8 项 RCT(包括 1634 名女性患者)被纳入我们的综述。与对照组相比,音乐干预明显降低了卵细胞采集或受精前的焦虑评分(标准化平均差(SMD):0.26,95 % CI:0.39 至 0.13,Z = 3.91,p < 0.0001)。此外,经过音乐治疗后,手术过程中的疼痛评分有了明显改善(SMD:0.96,95 % CI:1.72 至 -0.20,Z = 2.49,p = 0.01)。虽然与对照组相比,音乐干预组中有更多女性的临床妊娠率有所提高,但没有证据表明音乐干预对妊娠率有影响(SMD:0.14, 95 % CI:2.63 to 2.34, Z = 0.11, p = 0.91)。音乐干预可能会提高临床妊娠率,但在统计学上并不显著。要研究音乐干预对辅助生殖技术临床结果的影响,还需要更多样本量更大的研究。
{"title":"The effect of music interventions on anxiety, pain, and pregnancy rates in women undergoing fertility treatment before oocyte collection and embryo transfer: Systematic review and meta-analysis of randomized controlled trials","authors":"Mehtap Kızılkaya ,&nbsp;Aysu Yıldız Karaahmet ,&nbsp;Kerime Derya Beydağ","doi":"10.1016/j.eujim.2024.102408","DOIUrl":"10.1016/j.eujim.2024.102408","url":null,"abstract":"<div><h3>Introdution</h3><div>The present review aimed to evaluate the available evidence in the literature on the effect of music interventions on improving outcomes related to anxiety, pain, and pregnancy rates of women undergoing fertility treatment, prior to oocyte collection and embryo transfer.</div></div><div><h3>Method</h3><div>We searched the following databases from database inception to 2 May 2024, PUBMED, Embase, Web of Science, and the Turkish Academic Network and Information Center (ULAKBIM). Randomized controlled trials (RCT) in Turkish and English languages were included in the screening. Articles were scanned using MeSH-based keywords. The data were analyzed using the Review Manager computer program (Version 5.4.1).</div></div><div><h3>Results</h3><div>A total of 8 RCTs, including 1634 female patients, were included in our review. Music interventions significantly reduced anxiety scores prior to oocyte collection or fertilization compared to the control group (Standardised Mean Difference (SMD):0.26, 95 % CI:0.39 to 0.13, <em>Z</em> = 3.91, <em>p</em> &lt; 0.0001). Moreover, after the music treatment, there was a significant improvement in the pain score during the procedure (SMD:0.96, 95 % CI:1.72 to -0.20, <em>Z</em> = 2.49, <em>p</em> = 0.01). Although more women in the music interventions group experienced an increase in the clinical pregnancy rate compared to the control group, there was no evidence of an effect on pregnancy rate (SMD:0.14, 95 % CI:2.63 to 2.34, <em>Z</em> = 0.11, <em>p</em> = 0.91).</div></div><div><h3>Conclusion</h3><div>Music interventions appears to improve anxiety and pain scores in female patients receiving fertility treatment when administered during oocyte collection and fertilization. They may increase the clinical pregnancy rate but this not statistically significant. More research with larger sample sizes is needed to investigate the impact of music interventions on assisted reproductive technology clinical outcomes.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"72 ","pages":"Article 102408"},"PeriodicalIF":1.9,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1